The latest in health it & security: 6 developments from the past day, tracked and curated by the HealthTech Cube news desk. The lead story: AMA: PBM Market Concentration Is On the Rise.
AMA: PBM Market Concentration Is On the Rise
The AMA found that OptumRx, Express Scripts, CVS Caremark and Prime Therapeutics controlled 75% of the national PBM market in 2024. The post AMA: PBM Market Concentration Is On the Rise appeared first on MedCity News.
Sanofi Puts Up $1B to Expand Regeneron Alliance and Develop Next-Gen Dupixent
Sanofi and Regeneron Pharmaceuticals will collaborate on four next-generation antibody drugs that could offer advantages over Dupixent, the blockbuster immunology drug spawned by their R&D alliance. The companies project these drugs will start reaching pivotal testing in 2029 — important because Dupixent faces patent expiration in 2031. The post Sanofi Puts Up $1B to Expand Regeneron Alliance…
Follow the full firehose on the HTC Wire, refreshed automatically every day.